Drug Profile
Research programme: sphingosine-1-phosphate receptor agonist - Kyorin
Alternative Names: KRP-107Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Kyorin Pharmaceutical
- Class
- Mechanism of Action Sphingosine 1 phosphate receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Autoimmune disorders; Transplant rejection
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Autoimmune-disorders in Japan
- 16 Jul 2016 No recent reports of development identified for preclinical development in Transplant-rejection in Japan
- 02 Nov 2009 Preclinical trials in Autoimmune disorders in Japan (unspecified route)